Madrid, Spain

Antonio Cuadrado Pastor

This inventor holds 1 USPTO granted patent and 1 EPO patent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Cuadrado Pastor. Retrieved from https://idiyas.com/inventor/antonio-cuadrado-pastor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 1.0

ph-index = 1


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Cuadrado Pastor: Research and Patent Innovation

Introduction

Antonio Cuadrado Pastor is an inventor based in Madrid, Spain. His patent work addresses NRF2-related diseases associated with chronic inflammation and oxidative stress, with a particular focus on fatty liver disease.

Latest Patents

Cuadrado Pastor is associated with 1 patent: “Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease.” The invention describes NRF2-βTrCP interaction inhibitors, including compounds of a specified general formula and their derivative salts, for treating NRF2-related diseases. It specifically identifies liver diseases linked to chronic inflammation and oxidative stress, such as fatty liver disease.

Career Highlights

His listed organizational affiliations include the Biomedical Research Foundation of the Hospital Universitario de La Princesa and the Spanish National Research Council (Consejo Superior de Investigaciones Científicas). These affiliations connect his work with biomedical research and scientific investigation.

Collaborations

His named coworkers include Raquel Fernández Ginés and Rafael León Martínez. Their inclusion reflects the collaborative context associated with his research and patent activity.

Conclusion

Antonio Cuadrado Pastor’s patent focuses on potential inhibitors of the NRF2-βTrCP interaction as a research approach to treating fatty liver disease and other related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…